Blood Testing in Czechia

EliteMedical's Women's Cancer Prevention Programme is a structured oncological screening for women aged 40 and above, integrating internal medicine, tumour marker blood testing, and breast imaging into a coordinated programme. The first appointment at EliteMedical covers a comprehensive internal examination and a blood draw including gynaecological and oncological tumour markers (CA 125, CEA, and others based on individual risk profile). The breast imaging component — ultrasound or mammography, chosen based on age and breast density — is carried out at a partner radiology facility. All results are consolidated and reviewed by the EliteMedical physician, who contextualises the tumour marker values, imaging findings, and clinical examination to produce a comprehensive risk summary and prevention plan. The clinic cites evidence that early diagnosis can increase the chance of successful oncological treatment by up to 100%, and Prof. MUDr. Luboš Petruželka CSc. is available for oncological consultations for patients where follow-up is warranted.

Non-invasive prenatal testing (NIPT) at G-CENTRUM Olomouc analyses cell-free fetal DNA circulating in the mother's blood to screen for chromosomal conditions with 99% accuracy — far exceeding the 85–90% detection rate of standard combined screening. The clinic uses the TRISOMY test platform via SPADIA laboratory. A single blood draw from week 11 of pregnancy is all that is required; results are returned without any risk to the fetus (unlike amniocentesis or CVS). Four tiers of the test are available depending on how many conditions need to be screened.

IFCOR's Thrombophilia Genetic Panel is a comprehensive coagulation and genetics screen for people at elevated risk of inherited blood-clotting disorders. It combines haematological coagulation markers (CBC, prothrombin time, aPTT, fibrinogen, D-dimers, antithrombin) with molecular PCR testing for the five most clinically significant thrombophilia mutations: Factor V Leiden, Prothrombin gene G20210A, Factor XIII, MTHFR C677T, MTHFR A1298C, and PAI-1 4G/5G. Unlike coagulation function tests alone, genetic testing identifies permanent inherited risk that does not normalise with treatment — enabling lifelong risk-aware decisions about anticoagulation, hormonal contraception, pregnancy management, and surgery. Informed consent is required. Results are available within two weeks.

EliteMedical's Men's Cancer Prevention Programme combines internal medicine with a full urological examination led by Prof. MUDr. Tomáš Hanuš DrSc. — one of the Czech Republic's most distinguished urologists. The programme targets the two most prevalent male cancers: prostate cancer (the leading solid tumour in Czech men) and testicular cancer. Blood testing includes PSA (prostate-specific antigen), CEA, and other oncological markers selected by the physician based on the patient's age and risk profile. The urological component includes physical prostate examination and ultrasound of both the prostate and testes, providing structural information that PSA alone cannot offer. The entire programme is coordinated by a single physician who contextualises all results together and produces a written risk assessment and prevention plan. For men aged 20–40, testicular cancer screening is the priority; from age 50, prostate cancer screening takes precedence — though PSA baseline testing can begin from 40 in men with a family history.

EliteMedical's Comprehensive Allergy Panel is among the broadest commercially available allergy blood test panels in the Czech Republic — a single blood draw that simultaneously tests for IgE-mediated sensitisation against 117 allergen extracts and 178 molecular allergen components, covering pollen (trees, grasses, weeds), dust mites, mould, food allergens, animal danders, insect venom, and latex. Traditional skin prick testing requires multiple sessions and physical presence; this panel returns a complete sensitisation profile from one blood sample, with results discussed in an online physician consultation where a personalised allergy management plan is produced. Patients experiencing unexplained sneezing, runny nose, cough, breathing difficulties, eye or ear itching, skin eczema, urticaria, or gastrointestinal symptoms following food intake will receive a definitive allergic sensitisation map that guides both avoidance strategies and immunotherapy planning.

A DNA-based lifestyle and wellness report from partner lab GenePlanet, sold through the Vaše laboratoře group and sampled at Lab Med's Brno collection room. The analysis turns your genetic data into personalised lifestyle, nutrition and health-trait insights, available across five tiers from BASIC to PREMIUM. The shown price is the STANDARD tier; choose the tier at booking. Sampling is quick; the report is delivered by GenePlanet after laboratory processing.

Full-day preventive examination including blood tests, ECG, chest X-ray, ultrasound, and specialist consultations.

Full preventive health screening with advanced diagnostics.

Comprehensive cancer predisposition panel including BRCA1, BRCA2 and 11 additional genes.

MCP's whole-genome predictive screening provides a comprehensive map of your inherited disease risk across six major biological domains: metabolic, oncological, neurological, endocrine, cardiovascular, and immunological. The analysis is performed through MCP's accredited genomic lab partners and interpreted by MUDr. Silvie Růžičková (genetics) and MUDr. Radek Klubal. Unlike direct-to-consumer ancestry tests, this is a clinically framed risk assessment with actionable recommendations for screening frequency, lifestyle modification, and preventive intervention.

SPEA Olomouc operates a fully accredited ČIA ISO 15189 laboratory (accreditation No. 8146, held since 2011) and opens it to self-pay patients who do not hold a Czech health insurance card or whose specific tests are not covered by their insurer. The laboratory runs Roche Cobas 6000 for biochemistry and immunochemistry, Beckman Coulter DxH 500 and 900 analysers for haematology, and a Ceveron Alfa platform for coagulation — offering more than 80 analytes including the full lipid panel (with Lp(a) added in September 2025), thyroid function (TSH, fT3, fT4, anti-TPO, anti-TG), liver enzymes, kidney function, HbA1c, tumour markers (AFP, CEA, CA 125, CA 15-3, CA 19-9), and hormone panels (FSH, LH, prolactin, testosterone, estradiol, cortisol). Blood collection is accepted Monday to Friday from 6:30 to 12:00, with STATIM urgent processing available until 15:00.

Diagnostic blood testing supports the physicians at Poliklinika Kounicova in confirming diagnoses and monitoring treatment. Panels are requested by the GP or specialist according to clinical need and commonly include a complete blood count (CBC) to assess red cells, white cells and platelets, a thyroid panel (TSH with free T4 and free T3) to check thyroid function, and a lipid profile (total, LDL and HDL cholesterol and triglycerides) for cardiovascular risk. Testing is funded by Czech public health insurance when ordered by a doctor. Important: the polyclinic's own blood-draw room is currently not in operation, so the sample is taken at an associated collection point arranged by the clinic.

5P Medicine's food intolerance panel tests IgG antibody reactions to more than 270 foods, spices and additives — a far more extensive screen than standard IgE allergy tests which only catch immediate hypersensitivity reactions. IgG-mediated intolerances cause delayed, low-grade inflammation (typically hours to days after consumption) that can drive digestive symptoms, skin conditions, fatigue, headaches and chronic pain without an obvious food-symptom link. Results include a prioritised list of currently problematic foods, a roster of safe alternatives and a customised rotation diet plan. Patients with identified intolerances additionally receive a personalised cookbook with recipes that exclude their flagged foods.

5P Medicine's gut microbiome analysis uses a stool sample sent to Laboratoires REUNIS in Luxembourg for comprehensive profiling of bacterial and yeast microflora, digestive enzymes, intestinal biochemistry, fecal hemoglobin and intestinal permeability markers including zonulin. The resulting report identifies dysbiosis patterns — imbalances linked to food intolerances, weight gain, mood disorders, allergies and chronic inflammatory conditions — and is paired with personalised diet, probiotic and prebiotic recommendations. MUDr. Hora interprets results in the context of each patient's full health picture, often combining microbiome data with food intolerance IgG testing and inflammatory blood markers.